Andrew Goddard, M.D.
Andrew W. Goddard, M.D.
|Personal Statement||I have been engaged in the study and care of patients with anxiety and stress-related disorders for over 20 years now. This has been an exciting time to be in this field due to the tremendous improvements in treatments (psychotherapies and medicines) that have occurred during these decades and tremendous recent advances in neuroscience, which have enhanced our understanding of the functioning of fear circuits in the brain in health and illness. I hope this will lead to more individualized treatment planning and selection over the next few decades.|
|Education||Undergraduate: University of Melbourne
Medical School: University of Melbourne
Fellowship: Yale University
Diplomate, American Board of Psychiatry and Neurology
Fellow, Royal Australian & New Zealand College of Psychiatrists
|Current Academic Interests||Teaching: Involved in clinical teaching of third year medical students, and second, third and fourth year residents, and psychopharmacology fellows.
Clinical: Director of the Adult Psychiatry Outpatient Clinic and Study Center, and Director, IU Anxiety Clinic at Indiana University Hospital, and Consultant, University Hospital C-L Service.
Research: Main research initiatives involve ascertaining the role of combination medication treatment for difficult-to-treat panic disorder and OCD, and, determining neuroendocrine and neurochemical abnormalities that trigger anxiety and panic symptoms by means of modern neuroimaging methods such as MRI and MRS.
|Recent Publications||Krystal, J., G. Sanacora, G, Goddard, AW, Epperson, N, Mason, G (2008). "Gaba levels and the function of Glutamic Acid Decarboxylase in depression and panic disorder: Insights from MRS." International Journal of Neuropsychopharmacology 11: 73-73.
Goddard, A.W., Shekhar, A, Whiteman AF, Mcdougle CJ . Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discovery Today 13(7-8): 325-332, 2008
Kaabi B, Gelernter J, Woods SW, Goddard AW, Page GP, Elston RC. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: Strong evidence for a chromosome 4 risk locus. American Journal of Human Genetics, 78 (4): 543-553, 2006